(NASDAQ: GNFT) Genfit Sa's forecast annual revenue growth rate of -2.57% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 64.61%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.18%.
Genfit Sa's revenue in 2025 is $80,612,500.On average, 1 Wall Street analysts forecast GNFT's revenue for 2025 to be $3,466,735,468, with the lowest GNFT revenue forecast at $3,466,735,468, and the highest GNFT revenue forecast at $3,466,735,468. On average, 1 Wall Street analysts forecast GNFT's revenue for 2026 to be $3,913,201,400, with the lowest GNFT revenue forecast at $3,913,201,400, and the highest GNFT revenue forecast at $3,913,201,400.
In 2027, GNFT is forecast to generate $3,601,725,167 in revenue, with the lowest revenue forecast at $3,601,725,167 and the highest revenue forecast at $3,601,725,167.